Literature DB >> 10756151

Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease.

T P Prindiville1, R A Sheikh, S H Cohen, Y J Tang, M C Cantrell, J Silva.   

Abstract

We identified enterotoxigenic Bacteroides fragilis in stool specimens of patients with inflammatory bowel disease and other gastrointestinal disorders. The organism was detected in 11 (13.2%) of 83 patients with inflammatory bowel disease. Of 57 patients with active disease, 19.3% were toxin positive; none of those with inactive disease had specimens positive for enterotoxigenic Bacteroides fragilis gene sequences.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10756151      PMCID： PMC2640860          DOI： 10.3201/eid0602.000210

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  18 in total

1.  Detection of enterotoxigenic Bacteroides fragilis and its toxin in stool samples from adults and children in Italy.

Authors:  A Pantosti; M G Menozzi; A Frate; L Sanfilippo; F D'Ambrosio; M Malpeli
Journal:  Clin Infect Dis       Date:  1997-01       Impact factor: 9.079

Review 2.  Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease.

Authors:  R B Sartor
Journal:  Gastroenterol Clin North Am       Date:  1995-09       Impact factor: 3.806

3.  Purification and characterization of an enterotoxin from Bacteroides fragilis.

Authors:  R L Van Tassell; D M Lyerly; T D Wilkins
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

4.  Detection of Bacteroides fragilis enterotoxin gene by PCR.

Authors:  R Shetab; S H Cohen; T Prindiville; Y J Tang; M Cantrell; D Rahmani; J Silva
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

5.  Isolation of enterotoxigenic Bacteroides fragilis from Bangladeshi children with diarrhea: a controlled study.

Authors:  R B Sack; M J Albert; K Alam; P K Neogi; M S Akbar
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

6.  Human colonic epithelial cells, HT29/C1, treated with crude Bacteroides fragilis enterotoxin dramatically alter their morphology.

Authors:  C S Weikel; F D Grieco; J Reuben; L L Myers; R B Sack
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

7.  Design and evaluation of a 16S rRNA-targeted oligonucleotide probe for specific detection and quantitation of human faecal Bacteroides populations.

Authors:  J Doré; A Sghir; G Hannequart-Gramet; G Corthier; P Pochart
Journal:  Syst Appl Microbiol       Date:  1998-03       Impact factor: 4.022

8.  Association of Bacteroides fragilis with childhood diarrhea.

Authors:  V H San Joaquin; J C Griffis; C Lee; C L Sears
Journal:  Scand J Infect Dis       Date:  1995

9.  Detection of toxigenic Clostridium difficile in stool specimens by the polymerase chain reaction.

Authors:  N Kato; C Y Ou; H Kato; S L Bartley; C C Luo; G E Killgore; K Ueno
Journal:  J Infect Dis       Date:  1993-02       Impact factor: 5.226

10.  Detection of intestinal and extra-intestinal strains of enterotoxigenic Bacteroides fragilis by the HT-29 cytotoxicity assay.

Authors:  A Pantosti; M Cerquetti; R Colangeli; F D'Ambrosio
Journal:  J Med Microbiol       Date:  1994-09       Impact factor: 2.472
View more
  81 in total

Review 1.  The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models.

Authors:  Sandra Nell; Sebastian Suerbaum; Christine Josenhans
Journal:  Nat Rev Microbiol       Date:  2010-07-12       Impact factor: 60.633

2.  Strain competition restricts colonization of an enteric pathogen and prevents colitis.

Authors:  Aaron L Hecht; Benjamin W Casterline; Zachary M Earley; Young Ah Goo; David R Goodlett; Juliane Bubeck Wardenburg
Journal:  EMBO Rep       Date:  2016-07-18       Impact factor: 8.807

3.  Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.

Authors:  Sumathi Sankaran-Walters; Kanat Ransibrahmanakul; Irina Grishina; Jason Hung; Enrique Martinez; Thomas Prindiville; Satya Dandekar
Journal:  J Clin Virol       Date:  2010-10-28       Impact factor: 3.168

4.  Mutation of the zinc-binding metalloprotease motif affects Bacteroides fragilis toxin activity but does not affect propeptide processing.

Authors:  Augusto A Franco; Simy L Buckwold; Jai W Shin; Miguel Ascon; Cynthia L Sears
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Differences between tissue-associated intestinal microfloras of patients with Crohn's disease and ulcerative colitis.

Authors:  Uri Gophna; Katrin Sommerfeld; Sharon Gophna; W Ford Doolittle; Sander J O Veldhuyzen van Zanten
Journal:  J Clin Microbiol       Date:  2006-09-20       Impact factor: 5.948

6.  The C-terminal region of Bacteroides fragilis toxin is essential to its biological activity.

Authors:  Cynthia L Sears; Simy L Buckwold; Jai W Shin; Augusto A Franco
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease?

Authors:  Christelle Basset; John Holton; Alexandra Bazeos; Dino Vaira; Stuart Bloom
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

8.  Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-kappaB pathway.

Authors:  Shaoguang Wu; Jan Powell; Nes Mathioudakis; Sheryl Kane; Ellen Fernandez; Cynthia L Sears
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

Review 9.  Bacterial oncogenesis in the colon.

Authors:  Christine Dejea; Elizabeth Wick; Cynthia L Sears
Journal:  Future Microbiol       Date:  2013-04       Impact factor: 3.165

10.  Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice.

Authors:  Ki-Jong Rhee; Shaoguang Wu; Xinqun Wu; David L Huso; Baktiar Karim; Augusto A Franco; Shervin Rabizadeh; Jonathan E Golub; Lauren E Mathews; Jai Shin; R Balfour Sartor; Douglas Golenbock; Abdel R Hamad; Christine M Gan; Franck Housseau; Cynthia L Sears
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.